TCTR20211002001Enrolling By Invitation不适用
Correlation between serum squamous cell carcinoma antigen level and c-reactive protein with tumor volume in oral cavity cancer
/A0 个研究点目标入组 30 人开始时间: 2021年10月2日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Adult patients (18-80 years)
- •2. Patients were diagnosed with oral cavity squamous cell carcinoma
排除标准
- •1. Patients were diagnosed with pulmonary disease such as tuberculosis, adult respiratory distress syndrome ,pulmonary infiltration with eosinophilia, sarcoidosis and bronchogenic cyst
- •2. Patients were diagnosed with skin disease such as eczema, erythrodermic epidermitis, pemphigus and psoriasis
- •3. Patients were diagnosed with renal failure
研究者
相似试验
已完成
不适用
Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck CancerHead and Neck CancerNCT02879968Prince of Songkla University52
进行中（未招募）
1 期
Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis (sun spots) treated with ingenol disoxate gel or vehicleMedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic KeratosisEUCTR2017-000228-85-GBEO Pharma A/S563
进行中（未招募）
1 期
Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis (sun spots) treated with ingenol disoxate gel or vehicleMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic KeratosisEUCTR2017-000228-85-DEEO Pharma A/S850
招募中
不适用
Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the TongueSoft Tissue Tumors of the TongueProton Magnetic Resonance SpectroscopyTranscriptomicsSquamous Cell CarcinomaNCT06450080Centre Hospitalier Universitaire, Amiens60
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-DEEO Pharma A/S480